- T2 Biosystems Inc TTOO executed a territory-exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia.
- Under the terms of the agreement, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida, and T2Resistance Panels, through the distributor.
- Related: T2 Biosystems Q2 Sales Below Expectations, Sticks To Annual Guidance.
- The execution of this exclusive distribution agreement further expands T2 Biosystems' commercialization.
- Epidemiology studies have shown that the Baltic region has a higher average incidence of sepsis per population than Western Europe.
- Introducing the T2Dx Instrument and sepsis panels into these countries will allow rapid detection of sepsis-causing pathogens and antibiotic resistance genes in hours instead of days.
- Price Action: TTOO shares are up 17.79% at $0.1053 during the premarket session on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in